These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 3057836)

  • 21. Measuring the quality of colorectal cancer screening: the importance of follow-up.
    Etzioni DA; Yano EM; Rubenstein LV; Lee ML; Ko CY; Brook RH; Parkerton PH; Asch SM
    Dis Colon Rectum; 2006 Jul; 49(7):1002-10. PubMed ID: 16673056
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Mass screening of colorectal cancer by general practitioners in France: what is the real target population?].
    Desoubeaux N; Herbert C; Launoy G; Vallée JP; Bouvier V; Maurel J; Née E; Gignoux M
    Gastroenterol Clin Biol; 1997; 21(10):760-3. PubMed ID: 9587517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prevention and early detection of colorectal carcinoma by endoscopic examinations].
    Porschen R; Schmiegel W
    Z Gastroenterol; 1998 May; 36(5):403-14. PubMed ID: 9654708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Individual screening for colorectal cancer: which strategy for which patient?].
    Demols A; Van Laethem JL; Gay F; Franchimont D; Adler M; Van Gossum A
    Rev Med Brux; 2001 Sep; 22(4):A203-9. PubMed ID: 11680174
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer.
    Lindholm E; Brevinge H; Haglind E
    Br J Surg; 2008 Aug; 95(8):1029-36. PubMed ID: 18563785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Evaluation of usefulness of faecal occult blood test. Prospective screening study in patients with colorectal neoplasia].
    Banaszkiewicz Z; Jawień A; Jarmocik P; Tojek K; Jankowski M; Switoński M
    Pol Merkur Lekarski; 2004 Dec; 17(102):579-82. PubMed ID: 15771126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Colorectal cancer screening using fecal occult blood test and subsequent risk of colorectal cancer: a prospective cohort study in Japan.
    Lee KJ; Inoue M; Otani T; Iwasaki M; Sasazuki S; Tsugane S;
    Cancer Detect Prev; 2007; 31(1):3-11. PubMed ID: 17289293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Colorectal cancer mortality in two areas of Tuscany with different screening exposures.
    Costantini AS; Martini A; Puliti D; Ciatto S; Castiglione G; Grazzini G; Zappa M
    J Natl Cancer Inst; 2008 Dec; 100(24):1818-21. PubMed ID: 19066268
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validation of self-reported colorectal cancer screening behavior from a mixed-mode survey of veterans.
    Partin MR; Grill J; Noorbaloochi S; Powell AA; Burgess DJ; Vernon SW; Halek K; Griffin JM; van Ryn M; Fisher DA
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):768-76. PubMed ID: 18381474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The multidisciplinary management of gastrointestinal cancer. Colorectal cancer screening.
    Winawer SJ
    Best Pract Res Clin Gastroenterol; 2007; 21(6):1031-48. PubMed ID: 18070702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recommendations for colorectal cancer screening in ulcerative colitis: a review of research from a single university-based surveillance program.
    Lashner BA
    Am J Gastroenterol; 1992 Feb; 87(2):168-75. PubMed ID: 1531163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The case for population-based screening for colorectal cancer.
    Schoen RE
    Nat Rev Cancer; 2002 Jan; 2(1):65-70. PubMed ID: 11902587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survey of the opinions, knowledge, and practices of gastroenterologists regarding colorectal cancer screening and use of the fecal occult blood test.
    Sharma VK; Corder FA; Fancher J; Howden CW
    Am J Gastroenterol; 2000 Dec; 95(12):3629-32. PubMed ID: 11151904
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Colon rectal cancer: a common disease.
    Dewitt D
    Compr Ther; 1997 Dec; 23(12):785-7. PubMed ID: 9403230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A community-based program of colorectal screening in an asymptomatic population: evaluation of screening tests and compliance.
    Bat L; Pines A; Ron E; Niv Y; Arditi E; Shemesh E
    Am J Gastroenterol; 1986 Aug; 81(8):647-51. PubMed ID: 3740023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Limitations of the faecal occult blood test in screening for colorectal cancer.
    Delcò F; Sonnenberg A
    Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):119-26. PubMed ID: 10363196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening for colorectal cancer--United States, 1992-1993, and new guidelines.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1996 Feb; 45(5):107-10. PubMed ID: 8592492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Objectives and means of screening of colorectal cancer].
    Gignoux M; Valla A; Launoy G; Herbert C
    Rev Prat; 1994 Dec; 44(20):2700-5. PubMed ID: 7878359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sigmoidoscopy: a necessary practice?
    Roedde S
    Can Fam Physician; 1993 Dec; 39():2522, 2524. PubMed ID: 8292925
    [No Abstract]   [Full Text] [Related]  

  • 40. The importance of screening methods and familial risk factors in colorectal cancer.
    Griffiths EK; Schapira DV
    Prog Clin Biol Res; 1990; 339():331-9. PubMed ID: 2392429
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.